Project Grant R03AI194065
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$149K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Mississippi, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $185,280 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Texas A&M University System Health Science Center to study how the Mycobacterium tuberculosis (MTB) secreted protein Rv1075c hijacks host histone methyltransferases to promote infection. The key objectives are to define how histone methylation changes at innate immune genes during MTB infection, and investigate how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $382,500.00 to study the role of the protein TXLNA in innate immune responses to cytosolic DNA. The research aims to determine how TXLNA regulates the STING-mediated activation of TBK1, a key signaling pathway involved in the production of type I interferons in response to cytosolic DNA. The project will employ a...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $116,022 to The University of Texas Health Science Center at San Antonio to conduct research on the dimerization mechanism of the SARS-CoV-2 main protease enzyme. The awardee will develop quantitative luciferase-based reporter assays to study the structure-function relationship and conformational plasticity of the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $450,764.00 to Trustees of Tufts College, doing business as Tufts University School of Medicine, to conduct research on understanding the heterogeneity of necroptotic cell death and the mechanisms of necroptosis escape. The award period runs from June 23, 2025 to May 31, 2027. The key objectives of this research...
This federal Project Grant award of $479,249, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to study the molecular mechanisms regulating neutrophil proinflammatory activity in sepsis. The key objectives are to: Determine the molecular basis of neutrophil A20 signaling in regulating neutrophil proinflammatory function under septic conditions. Utilize two-photon intravital...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate the sirtuin-dependent regulation of tuberculosis (TB) and HIV interactions in macrophages. The total award amount is $1,297,775.00 over a 5-year period from August 1, 2024 to July 31, 2029. The primary objectives are to: 1) analyze the impact of early TB and HIV infection on sirtuin gene and protein...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $162,000 in funding to The Washington University to conduct research on the role of plasmacytoid dendritic cells (pDCs) in Mycobacterium tuberculosis (MTB) infection. The goal is to characterize pDC function during MTB infection to identify potential pDC-specific therapeutic targets that could lead to host-directed...
This Project Grant award, valued at $156,080.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to determine how the LY49C inhibitory receptor on natural killer (NK) cells can distinguish different peptides loaded onto MHC-I molecules, and how this influences NK cell function and potential for "trained immunity". The research aims to demonstrate...
This federal Project Grant award of $787,171 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop novel 1,2,4-triazole and pyrrolidine compounds as potential treatments for tuberculosis (TB). The primary objectives are to demonstrate preclinical proof-of-concept for these compound classes, optimize their pharmacological properties, and investigate their unique mechanism of action compared...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $239,120 to Tufts University School of Medicine to analyze the heterogeneity of cell death responses in influenza virus-infected cells. The research aims to understand the interplay between transcriptional programs and different forms of cell death during viral infection, with the goal of elucidating which cell death...